Topical formulation of retinyl retinoate employing nanostructured lipid carriers

다국어 초록 (Multilingual Abstract)

Topical formulation of retinyl retinoate (RR)was developed with nanostructured lipid carriers (NLCs),composed of Compritol or Precirol as a solid lipid, canola oil as an oil, and Tween 80 as a surfactant. Hot high pressure homogenization method was efficiently employed to yield a homogenous nanodispersion in the size range of 230–300 nm with PDI values of\0.2, regardless of lipid selection. Precirol-based NLC (P-NLC) showed higher drug entrapment than that of Compritol-based NLC (C-NLC): RR encapsulation efficiency (%) of P- and C-NLC was 97.8 and 93.8 in average, respectively; drug loading (mg RR/g lipid)was 89.6 and 83.3 in average, respectively. Processing condition at relatively low temperature of 60 C was a key factor for maintaining RR stability. Drug release of P-NLC was greater than that of C-NLC, even though both NLCs revealed controlled release pattern. Therefore, P-NLC system was considered as a suitable vehicle for topical drug delivery, especially for heat-labile ingredient like RR.

참고문헌 (Reference)

1 de Vringer T, "Topical preparation containing a suspension ofsolid lipid particles"

2 Kim BH, "The mechanism of retinol-inducedirritation and its application to anti-irritant development" 146 : 65-73, 2003

3 Schurer NY, "The biochemistry and function ofstratum corneum lipids" 24 : 27-56, 1991

4 de Lorgeril M, "The Mediterranean-style diet for theprevention of cardiovascular diseases" 9 : 118-123, 2006

5 정형일, "Synthesis and in vitro biological activity of retinyl retinoate, a novel hybrid retinoid derivative" PERGAMON-ELSEVIER SCIENCE LTD 16 : 6387-6393, 200806

6 Mu¨ller RH, "Solid lipid nanoparticles(SLN) and nanostructured lipid carriers (NLC) in cosmetic anddermatological preparations" 54 : 131-155, 2002

7 Zhai H, "Skin occlusion and irritant and allergiccontact dermatitis: an overview" 44 : 201-206, 2001

8 Roos TC, "RetinoidMetabolism in the skin" 50 : 315-333, 1998

9 Shen H, "Preparation and evaluation of selfmicroemulsifying drug delivery system (SMEDDs) containingatorvastatin" 58 : 1183-1191, 2006

10 Morais J, "Physicochemical characterization of canola oil/water nanoemulsionsobtained by determination of required HLB numberand emulsion phase inversion" 27 : 109-115, 2006

11 Puglia C, "Lipid nanoparticles for prolonged topical delivery: an invitro and in vivo investigation" 357 : 295-304, 2008

12 Liu J, "Isotretinoin-loadedsolid lipid nanoparticles with skin targeting for topical delivery" 328 : 191-195, 2007

13 Wanasundara U, "Isolation andidentification of an antioxidative component in canola meal" 42 : 1285-1290, 1994

14 Wissing S, "Investigations on theocclusive properties of solid lipid nanoparticles (SLN)" 52 : 313-324, 2001

15 Pardeike J, "Influence of nanostructuredlipid carriers (NLC) on the physical properties of theCutanova Nanorepair Q10 cream and the in vivo skin hydrationeffect" 396 : 166-173, 2010

16 정형일, "Improvement in skin wrinkles from the use of photostable retinyl retinoate: a randomized controlled trial" WILEY-BLACKWELL PUBLISHING 162 : 497-502, 201003

17 Patlolla RR, "Formulation, characterization and pulmonary depositionof nebulized celecoxib encapsulated nanostructured lipid carriers" 144 : 233-241, 2010

18 Lim SJ, "Formulation parameters determining thephysicochemical characteristics of solid lipid nanoparticlesloaded with all-trans retinoic acid" 243 : 135-146, 2002

19 Touitou E, "Ethosomes—novel vesicular carriers for enhanced delivery:characterization and skin penetration properties" 65 : 403-418, 2000

20 Woo Sik Choi, "Enhanced Occlusiveness of Nanostructured Lipid Carrier (NLC)-based Carbogel as a Skin Moisturizing Vehicle" 한국약제학회 40 (40): 373-378, 2010

21 Teeranachaideekul V, "Encapsulationof ascorbyl palmitate in nanostructured lipid carriers(NLC)—effects of formulation parameters on physicochemicalstability" 340 : 198-206, 2007

22 Kristl J, "Effect ofcolloidal carriers on ascorbyl palmitate stability" 19 : 181-189, 2003

23 Orfanos CE, "Current use and future potential role of retinoids in dermatology" 53 : 358-388, 1997

24 Wissing SA, "Cosmetic applications for solid lipidnanoparticles (SLN)" 254 : 65-68, 2003

25 Kang S, "Application ofretinol to human skin in vivo induces epidermal hyperplasia andcellular retinoid binding proteins characteristic of retinoic acidbut without measurable retinoic acid levels or irritation" 105 : 549-556, 1995

26 Kuwahara H, "Antioxidative and antimutagenicactivities of 4-vinyl-2,6-dimethoxyphenol (Canolol) isolatedfrom canola oil" 52 : 4280-4287, 2004